Two-year prospective natural history study of EYS-associated retinitis pigmentosa using adaptive optics: the KEYS study

Masakazu H., Akiko M., Midori Y., Elena G.-S., Shohei K., Satoshi Y., Yuki T., Masanao T., Shuhei K., Yasuhiko H., Yasuo K., Kiyoko G.

2026
Scientific Reports

View publication

Therapeutic Area

Back of the eye (BOTE)
Categories

Clinical development, Sponsored/funded by Santen

Affiliations

Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe, 650-0047, Hyogo, Japan. hiraoka@vision-care.jp; Kawasaki Medical University, Kurashiki, Okayama, Japan. hiraoka@vision-care.jp; Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe, 650-0047, Hyogo, Japan; Ritsumeikan University, Kyoto, Kyoto, Japan; Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, Paris, 75012, France; Yokohama City University, Yokohama, Kanagawa, Japan; Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan; Santen Pharmaceutical Co., Ltd., Osaka, Osaka, Japan; Kawasaki Medical University, Kurashiki, Okayama, Japan; Hôpital National des Quinze-Vingts, Paris, Île-de-France, France.

Related Publications

Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective

Shi-van Wielink K., Dahlmann-Noor A., Li J., de Milliano T.W.L., Ernst F., Croci F., Sharma Y., Punekar Y.

Prospective natural history and clinical biomarkers of EYS-associated retinopathy in the KEYS study

Taniguchi M, Togashi Y, Yokota S, Hiraoka M, Kitahata S, Nakamura N, Yamamoto M, Mandai M, Gocho K, Toshimori M, Hirami Y, Gomi F, Kurimoto Y, Maeda A.

STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24‑Month Results of a Randomized, Double‑Masked, Vehicle‑Controlled Trial of Atropine Sulfate 0.01% and 0.03%

Korenfeld M.; Hurcikova M.; Tatsuoka K.; Cheetham J.; Kacerik M.; on behalf of the STAR Study Investigators

View all Back of the eye (BOTE) publications